Skip to main content
. 2012 Jan 31;80(2):337–351. doi: 10.3797/scipharm.1108-04

Tab. 3.

Robustness evaluationa of the method (n=6)

Retention time (tR) Asymmetry (T)

Factor Level ACF PCM TRM ACF PCM TRM
Flow Rate (mL min−1)

0.9 −1 15.336 3.316 7.958 1.27 1.22 1.01
1.0 0 14.648 3.137 7.850 1.27 1.22 1.02
1.1 +1 13.950 2.972 7.768 1.26 1.23 1.00
Mean ± S.D. 14.645 3.142 7.859 1.27 1.22 1.01
± 0.69 ± 0.17 ± 0.10 ± 0.01 ± 0.01 ± 0.01

Percentage of methanol in the mobile phase (v/v)

59 −1 15.213 3.156 7.923 1.29 1.17 1.03
60 0 14.648 3.137 7.850 1.27 1.22 1.02
61 +1 14.186 3.092 7.762 1.27 1.21 1.02
Mean ± S.D. 14.682 3.128 7.845 1.28 1.20 1.02
± 0.51 ± 0.03 ± 0.08 ± 0.01 ± 0.03 ± 0.01

pH of the buffer

5.90 −1 14.693 3.133 7.795 1.28 1.25 1.01
6.00 0 14.648 3.137 7.850 1.27 1.22 1.02
6.10 +1 14.617 3.138 7.898 1.24 1.22 1.00
Mean ± S.D. 14.653 3.136 7.848 1.26 1.23 1.01
± 0.04 ± 0.01 ± 0.05 ± 0.02 ± 0.02 ± 0.01

Columns from different manufacturers

HiQ-Sil™ HS C18 14.648 3.137 7.850 1.27 1.22 1.02
BDS Hypersil C18 14.650 3.142 7.858 1.34 1.28 1.08
Mean ± S.D. 14.649 3.139 7.854 1.31 1.25 1.05
± 0.001 ± 0.003 ± 0.006 ± 0.04 ± 0.04 ± 0.04
a

Average of three concentrations 40, 100, and 160 μg mL−1 for ACF, 130, 325 and 520 μg mL−1 for PCM and 15, 37.5 and 60 μg mL−1 for TRM.